Home >> Business >> Hospital Infection Prevention And Control Market (6.3 % CAGR) 2016 to 2024: Global Industry Size, Share, Growth, Trends and Forecast

Hospital Infection Prevention And Control Market (6.3 % CAGR) 2016 to 2024: Global Industry Size, Share, Growth, Trends and Forecast

The latest market report published by Credence Research, Inc., the global hospital infection prevention and control market was valued at US$ 142.6 million in 2015 and is expected to reach US$ 245.6 million by 2024, increasing to CAGR by 6.3 per cent from 2016 to 2024.

Market Insights

Market experts suggest that health-related infections are a costly issue facing many hospitals around the globe. Hospital acquired infections are a type of infection that is observed in patients with unrelated conditions during treatment. According to the World Health Organization (WHO), infectious waste contributes in this way to the risk of nosocomial infections, putting hospital personnel and patients at risk. The Centers for Disease Control and Prevention (CDC) statistically suggested that, with approximately 300,000 occurrences per year, surgical site infections (SSIs) are the second most prevalent HAI in the United States, preceded only by urinary tract infections. At a cost of approximately US$ 10 billion annually, this high incidence of SSIs has a significant impact on the U.S. healthcare system as well as on the bottom line of individual hospitals.

Browse Full Report Originally Published by Credence Research at https://www.credenceresearch.com/report/hospital-infection-prevention-and-control-market

The occurrence of nosocomial infections has been seen worldwide in both developed and resource-poor countries. The key factors contributing to the growth of the hospital infection prevention and control market are increasing prevalence of infections, the implementation of strict guidelines for the prevention and control of hospital infections, the development of healthcare infrastructure in emerging countries and an increasing number of hospitals worldwide.

The global hospital infection prevention and control market is segmented by type of infection such as pneumonia, urinary tract infection, bloodstream infection, surgical site infection, MRSA and others. These are the main types of hospital-acquired infections that have the highest prevalence. As a CDC source, ventilator-associated pneumonia and surgical site infection are the most common conditions followed by GI, UTI, and primary bloodstream infections.

Global Hospital Infection Prevention and Control Market are segmented by Product type as Infection Prevention Supplies, Infection Prevention Equipment and Infection Prevention Services. Infection prevention supplies held the largest share in the overall hospital infection prevention and control market.

As of the current market scenario, North America formed the largest market for hospital infection prevention and control market due to rising prevalence of the nosocomial infection and stringent regulation followed by the hospitals, clinicians and care givers aligning with regulatory bodies. Asia Pacific is the fastest growing segment with increase in awareness of the healthcare associated infection, rising investment in health care infrastructure, technological advancement and new protocols and programs conducted for infection prevention and control in line with WHO guidelines.

Market Competition Assessment:

Key players in the Hospital Infection Prevention Control market are

3M Company, Ansell Ltd., Becton, Dickinson and Company, Belimed AG, Bemis Company, Inc., B. Braun Melsungen AG, Cantel Medical Corp., Cantel Medical Corp., Covidien plc, Crosstex International, Inc., Danaher Corp., Diversey, Inc., Getinge Group, Johnson & Johnson, Halyard Health, Inc., MMM Group, Matachana Group, Medivators, Inc., Purdue Pharma LP, Sealed Air Corp, Semperit AG Holding, Synergy Health plc, and Terumo Corp.

Key Market Movements:

  • Hospital acquired infections are a growing issue of preventable disease burden in respect of morbidity and mortality in all countries. Nosocomial infection is major cause of concern for the patient and as well as the health care providers. The rising prevalence of the nosocomial infection is major driving factor for hospital infection and prevention market.
  • WHO and various others regulatory bodies at regional and national level provide guidelines for hospital infection prevention and control. The significant steps taken to control infection include to identify patients at risk of nosocomial infection, maintaining the hand hygiene, practicing standard precautionary measure to reduce the transmission and applying novel strategies to reduce VAP, CR-BSI, and CAUTI.
  • In Emerging economies, there is rise in R&D and increase government initiative in health care sector. There has being introduction of key corporate hospital chains, which play major role in driving the growth and the expansion of the healthcare sector. With this rise in the number of hospital increases the chances of nosocomial infection.

You can get the sample copy of this research by Credence Research here: https://www.credenceresearch.com/sample-request/58360

Report Scope by Segments

By Product Type

  • Infection Prevention Supplies
    • Disinfectants
    • Protective Apparel & Textiles
    • Safety-Enhanced Medical Devices
    • Sterilization Supplies
    • Medical Waste Disposal Supplies
  • Infection Prevention Equipment
    • Endoscope Reprocessors
    • Sterilization Equipment
    • Washing/Disinfecting Equipment
    • Other Infection Prevention Equipment
  • Infection Prevention Services
    • Endoscope Reprocessors
    • Sterilization Equipment
    • Washing/Disinfecting Equipment
    • Other Infection Prevention Equipment

By Infection Type

  • Pneumonia
  • Urinary Tract Infection
  • Blood Stream Infection
  • Surgical Site Infection
  • MRSA
  • Others

By Geography Segment

 • North America (U.S., Rest of North America)

 • Europe (U.K., Germany, France, Rest of Europe)

 • Asia Pacific (China, Japan, India,Rest of Asia Pacific)

 • Rest of the World (Middle East & Africa, Latin America)

Find more research reports on Pharmaceuticals Industry, by Credence Research

Leave a Reply

Your email address will not be published. Required fields are marked *